Systemic lupus erythematosus – Diagnostics – Overview of Information and Clinical Research

Diagnosing systemic lupus erythematosus is like solving a complex puzzle where each piece comes from a different part of the body. There is no single test that can confirm lupus on its own. Instead, doctors rely on a combination of blood tests, physical examinations, and careful observation of symptoms that may affect the skin, joints, kidneys, heart, or other organs. Because lupus can look very different from one person to another, and because its symptoms often mimic other conditions, getting an accurate diagnosis requires patience, thoroughness, and close collaboration between patients and their healthcare team.

Introduction: When to Seek Diagnostic Testing

Anyone experiencing a combination of unexplained symptoms that affect multiple body systems should consider discussing the possibility of lupus with their doctor. This is especially important if you notice a pattern of joint pain and swelling that comes and goes, unexplained fevers that have no clear cause, or skin rashes that appear after being in the sun. The classic butterfly-shaped rash across the cheeks and nose is one of the most recognizable signs, though it only appears in about half of people with lupus.^[1]

Women between the ages of 15 and 44 should be particularly attentive to these symptoms, as lupus affects women nearly ten times more often than men.^[1] People from certain racial and ethnic backgrounds also face higher risk. African Americans, Hispanic Americans, Asian Americans, African Caribbeans, and Native Americans develop lupus more frequently than non-Hispanic white people.^[1] If you have a close family member with lupus or another autoimmune disease, this increases your risk as well, making it even more important to seek evaluation if concerning symptoms appear.^[3]

Early diagnosis matters tremendously because lupus is better managed when it is identified and treated promptly. Delayed diagnosis can lead to complications affecting the kidneys, heart, or other vital organs.^[7] If you notice symptoms such as extreme tiredness that does not improve with rest, persistent hair loss, mouth sores that recur, chest pain when taking deep breaths, or swelling in your legs or around your eyes, these warrant a conversation with your healthcare provider. Even if your symptoms seem mild or come and go, documenting them and bringing them to your doctor’s attention can help catch lupus before it causes serious damage.

It is also important to seek medical attention if you develop neurological symptoms such as headaches that are different from your usual pattern, memory problems, confusion, seizures, or vision changes. These can indicate that lupus is affecting the brain or nervous system, which requires specialized evaluation and treatment.^[1] The key is not to wait until symptoms become severe or debilitating, but rather to pursue testing when patterns emerge that suggest something more than isolated, temporary health issues.

Classic Diagnostic Methods for Identifying Lupus

Diagnosing lupus requires a careful, methodical approach because no single test can definitively confirm the disease. Instead, doctors use classification criteria developed by major rheumatology organizations to guide their evaluation. The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) published updated criteria in 2019 that represent current concepts of how to classify lupus. These criteria have excellent specificity and sensitivity, meaning they are very good at correctly identifying who has lupus and who does not.^[6]

The 2019 ACR/EULAR classification requires an antinuclear antibody (ANA) test as an essential first step. An ANA test looks for antibodies that your immune system produces against components of your own cell nuclei. To meet the entry criterion, you must have a positive ANA titer of at least 1:80 on a specific type of cell test (HEp-2 cells) or an equivalent positive result on a similar test. Nearly all people with lupus have a positive ANA test. However, having a positive ANA alone does not mean you have lupus, since many healthy people and people with other conditions can also test positive for ANA.^[1]^[11]

Once a positive ANA is confirmed, doctors consider 22 additional weighted criteria across seven clinical domains. These domains include constitutional symptoms (such as fever), blood abnormalities, skin manifestations, joint problems, kidney involvement, nervous system symptoms, and other specific findings. Each criterion is assigned a point value based on how strongly it suggests lupus. Patients need to accumulate at least 10 points across these categories to be classified as having lupus according to these criteria.^[6]^[12]

During the diagnostic process, your healthcare provider will perform a complete physical examination. They will look for visible signs such as skin rashes, particularly the butterfly rash across the cheeks and nose, or discoid lesions (round, raised patches). They will check your joints for swelling, tenderness, or signs of arthritis. They may listen to your heart and lungs with a stethoscope to detect abnormal sounds like a pericardial friction rub (a sound indicating inflammation of the sac around the heart) or a pleural friction rub (indicating inflammation of the lining around the lungs). They will also examine your ankles and legs for swelling that might suggest kidney problems.^[1]

Blood tests form the cornerstone of lupus diagnosis. Beyond the ANA test, doctors typically order a complete blood count (CBC) to look for anemia, low white blood cell counts, or low platelet counts, all of which can occur in lupus. An erythrocyte sedimentation rate (ESR) measures how quickly red blood cells settle in a test tube, which can indicate inflammation, though this test is not specific to lupus. A C-reactive protein (CRP) test is another measure of inflammation in the body.^[1]

⚠️ Important

Having a positive ANA test does not automatically mean you have lupus. Many healthy people have positive ANA results, and the test can also be positive in other autoimmune diseases. Your doctor will need to evaluate your complete medical picture, including symptoms, physical examination findings, and additional specialized blood tests, before making a diagnosis. Never try to diagnose yourself based on a single test result.

More specific antibody tests help distinguish lupus from other conditions. Tests for antibodies to double-stranded DNA (anti-dsDNA) are quite specific for lupus, meaning that if they are positive, lupus is very likely. Complement components (C3 and C4) are proteins in your blood that are part of the immune system. In active lupus, these levels often drop because they are being consumed in the inflammatory process. Your doctor may also test for anti-Smith antibodies, which are highly specific for lupus but only present in about 30 percent of lupus patients.^[1]^[6]

Testing for antiphospholipid antibodies and lupus anticoagulant is important because these antibodies increase the risk of blood clots, strokes, and pregnancy complications. People with lupus who have these antibodies may need special monitoring and treatment. A Coombs test checks whether your immune system is attacking your red blood cells, which can cause a type of anemia called autoimmune hemolytic anemia.^[1]

Urine tests are essential for detecting kidney involvement, which occurs in many people with lupus. A simple urinalysis can show the presence of protein or red blood cells in the urine, early signs that the kidneys are being affected. Your doctor will also check your serum creatinine level, a blood test that measures kidney function. If there are signs of kidney involvement, your doctor may recommend a kidney biopsy, where a small sample of kidney tissue is removed with a needle and examined under a microscope to determine the type and severity of kidney inflammation.^[1]

Imaging tests help evaluate whether lupus is affecting internal organs. A chest X-ray can show fluid buildup around the lungs or signs of lung inflammation. More specialized imaging tests might include ultrasound of the heart (echocardiogram) to check for valve problems or inflammation around the heart, or imaging of the brain if neurological symptoms are present. These tests help doctors understand the full extent of organ involvement and guide treatment decisions.^[1]

Distinguishing lupus from other conditions is a critical part of the diagnostic process. Many diseases can produce similar symptoms, including other autoimmune conditions like rheumatoid arthritis, infections, cancers, and even some medication side effects. Your doctor will carefully consider all possible explanations for your symptoms. The pattern of symptoms affecting multiple organ systems, the specific antibody profile, and the way symptoms come and go over time all help point toward lupus versus another condition.^[4]

Diagnostics for Clinical Trial Qualification

When patients are being considered for enrollment in clinical trials studying new lupus treatments, the diagnostic requirements often follow standardized classification criteria very closely. Clinical trials need to ensure that all participants truly have lupus and that their disease severity is similar enough to make the study results meaningful. The 2019 ACR/EULAR classification criteria are now commonly used as entry criteria for lupus clinical trials.^[6]

Most clinical trials require documented evidence of a positive ANA test at a specified titer level, typically 1:80 or higher. They also require that patients meet the point threshold (usually 10 points or more) based on the weighted criteria that include clinical symptoms and immunologic markers. This means trial participants must have documentation of specific symptoms, physical examination findings, and laboratory test results that together confirm the diagnosis according to these standardized criteria.^[12]

Trials often measure disease activity using standardized scoring systems. The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) is one such tool that assigns points based on the presence of 24 different clinical and laboratory features across nine organ systems. A modified version called SLEDAI-2K allows doctors to track persistent symptoms like hair loss, skin rashes, and protein in the urine that might not be new but are still active. These scoring systems help determine whether a patient has enough disease activity to be eligible for a trial and whether the treatment being studied is helping.^[15]

Many clinical trials require regular monitoring of specific blood tests to track disease activity and safety. This typically includes repeated measurements of anti-double-stranded DNA antibodies, complement levels (C3 and C4), complete blood counts, kidney function tests, and liver function tests. Some trials may also track C-reactive protein levels. These tests are performed at screening (before enrollment), at baseline (when starting the trial), and at regular intervals throughout the study.^[12]

Trials studying lupus treatments that specifically target kidney involvement (lupus nephritis) have additional diagnostic requirements. Patients typically must have had a kidney biopsy within a certain time frame before enrollment that shows a specific class of lupus nephritis (usually Class III, IV, or V based on standardized pathology classification). They must also have evidence of active kidney disease at the time of screening, such as specific levels of protein in their urine or changes in kidney function blood tests.^[4]

Patients being screened for clinical trials undergo thorough physical examinations and detailed assessments of which organ systems are affected by their lupus. Doctors document the presence or absence of features like skin rashes, mouth ulcers, joint inflammation, hair loss, and signs of inflammation in the heart, lungs, or nervous system. This comprehensive assessment helps match patients to trials studying treatments for their specific manifestations of lupus.

Some trials require documentation of previous treatments and responses. For example, a trial might only enroll patients who have not responded adequately to standard treatments like hydroxychloroquine or corticosteroids. This requires medical records showing what treatments were tried, at what doses, for how long, and how well they worked. This information helps ensure that the trial is testing the new treatment in the right population of patients.

Safety screening is also a crucial part of trial qualification. Patients must have blood tests and other evaluations to ensure they do not have active infections, certain types of cancer, severe kidney or liver dysfunction, or other conditions that might make it unsafe for them to participate. Pregnancy testing is required for women of childbearing age, as many lupus treatments cannot be used during pregnancy. These safety measures protect participants while allowing researchers to gather reliable data about new treatments.

Prognosis and Survival Rate

Prognosis

The outlook for people living with lupus has improved dramatically over the past several decades, largely due to earlier diagnosis, better treatments, and more comprehensive understanding of the disease. The course of lupus varies tremendously from person to person. Some people experience mild symptoms that primarily affect the skin and joints, while others develop serious complications involving the kidneys, heart, lungs, or nervous system. The severity of your lupus, which organs are affected, how quickly you receive appropriate treatment, and how well you follow your treatment plan all influence your long-term prognosis.^[6]

Several factors can worsen the effects of lupus and potentially affect outcomes. Not having access to regular healthcare, receiving a diagnosis long after symptoms began, and not following prescribed treatment plans can all lead to worse disease progression and increased risk of complications. This is why early detection and consistent medical care are so important.^[7] Certain demographics face additional challenges. The disease tends to be more common and sometimes more severe in African Americans, Hispanic Americans, Asian Americans, and Native Americans compared to non-Hispanic white populations.^[1]

Kidney involvement (lupus nephritis) is one of the most serious complications and can affect up to 60 percent of people with systemic lupus erythematosus. For most people who develop lupus nephritis, symptoms appear within five years of their initial lupus diagnosis. The type and severity of kidney inflammation, how quickly treatment begins, and how well the kidneys respond to therapy all influence kidney-related outcomes.^[2] Neuropsychiatric symptoms affecting the brain occur in more than one in five people with lupus and can include headaches, difficulty thinking clearly, memory problems, seizures, or stroke.^[2]

Heart disease is a significant concern for people with lupus. The chronic inflammation associated with lupus increases the risk of heart attacks and strokes, and these events can occur at younger ages than in the general population. This makes it crucial to work with healthcare providers to manage other heart disease risk factors like high cholesterol, high blood pressure, and diabetes. Not smoking, maintaining a healthy weight, and staying physically active also contribute to better cardiovascular outcomes.^[1]^[12]

With proper treatment and self-care, many people with lupus can achieve periods of remission where they have few or no symptoms. The goal of modern lupus treatment is to achieve complete remission or at least low disease activity while minimizing the use of medications that have significant side effects, particularly corticosteroids. Advances in targeted biological therapies and better treatment strategies are helping more people reach these goals and maintain better quality of life.^[12]^[13]

Survival Rate

Survival rates for people with systemic lupus erythematosus have improved remarkably over the decades. Historical data shows that in 1955, only about 53 percent of people diagnosed with lupus survived five years. Today, the ten-year survival rate exceeds 90 percent, representing tremendous progress in understanding and managing this complex disease.^[4] This improvement reflects earlier diagnosis through better awareness and testing, more effective medications including both traditional immunosuppressants and newer biological therapies, and comprehensive approaches to managing both the disease itself and its complications.

More than 90 percent of people with lupus can expect to live normal, healthy lives with appropriate treatment and self-management.^[7]^[25] However, survival and outcomes are not uniform across all populations. Certain groups, including minorities and people with limited access to healthcare, may experience worse outcomes. Socioeconomic factors, delayed diagnosis, and differences in disease severity between ethnic groups all contribute to these disparities.^[6]

The leading causes of death in people with lupus have shifted over time. In the past, uncontrolled lupus activity and kidney failure were the primary causes. Today, with better disease control, infections and cardiovascular disease (heart attacks and strokes) have become more significant concerns. Infections remain dangerous because lupus itself affects the immune system, and many lupus medications further suppress immunity. This is why staying up to date with vaccinations, promptly treating infections, and taking preventive measures are so important.^[7]

Individual prognosis depends on multiple factors including the specific organs affected, the severity of involvement, how early treatment begins, how well you respond to medications, and whether you experience serious complications. People who develop severe kidney disease, significant heart or lung involvement, or nervous system complications may face more challenges. However, even with serious organ involvement, many people achieve good control with modern treatments. Adhering to medication regimens, attending regular follow-up appointments, monitoring for signs of flares, and maintaining healthy lifestyle habits all contribute to better long-term outcomes.^[12]

Pregnancy outcomes for women with lupus have also improved significantly. While lupus does increase the risk of pregnancy complications including miscarriage, stillbirth, preeclampsia, and restricted fetal growth, many women with lupus successfully carry pregnancies to term and deliver healthy babies. Careful preconception planning, close monitoring throughout pregnancy by a multidisciplinary team, and continuing certain medications like hydroxychloroquine during pregnancy all contribute to better maternal and fetal outcomes.^[12]

#1 Clinical Trials Search in Europe